Tang Liu, Li Xiaolei, Wan Liping, Xiao Yao, Zeng Xin, Ding Hong
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Front Pharmacol. 2019 Mar 29;10:182. doi: 10.3389/fphar.2019.00182. eCollection 2019.
Irinotecan (CPT-11), a water-soluble derivative of camptothecin, belongs to the class of DNA topoisomerase I inhibitors and has been approved worldwide for the treatment of advanced colorectal cancer, lung cancer, and malignant lymphoma. Although CPT-11-based chemotherapy is widely used, severe gastrointestinal (GI) toxicity, especially late-onset diarrhea, is a common adverse reaction, limiting clinical application of the drug. The incidence of grade 3 or 4 diarrhea is high, with 20-40% of CPT-11-treated patients experiencing this adverse effect. High-dose loperamide and octreotide are generally recommended for treatment of CPT-11-induced diarrhea. However, in clinical practice, loperamide is associated with a significant failure rate and the beneficial effects of octreotide are controversial. An accumulating number of recent studies have suggested that medicinal herbs and their derived phytocompounds may be effective complementary treatments for CPT-11-induced diarrhea. In this mini-review, we briefly summarize currently available literatures regarding the formulae and herbs/natural products used as adjuvants in animal and clinical studies for the treatment of diarrhea caused by CPT-11.
伊立替康(CPT-11)是喜树碱的水溶性衍生物,属于DNA拓扑异构酶I抑制剂类,已在全球范围内获批用于治疗晚期结直肠癌、肺癌和恶性淋巴瘤。尽管基于CPT-11的化疗被广泛应用,但严重的胃肠道(GI)毒性,尤其是迟发性腹泻,是一种常见的不良反应,限制了该药物的临床应用。3级或4级腹泻的发生率很高,20%-40%接受CPT-11治疗的患者会出现这种不良反应。高剂量洛哌丁胺和奥曲肽通常被推荐用于治疗CPT-11引起的腹泻。然而,在临床实践中,洛哌丁胺的失败率很高,奥曲肽的疗效也存在争议。最近越来越多的研究表明,草药及其衍生的植物化合物可能是治疗CPT-11引起的腹泻的有效辅助疗法。在本综述中,我们简要总结了目前关于在动物和临床研究中用作辅助治疗CPT-11引起的腹泻的方剂和草药/天然产物的文献。